Press release

LICT Corporation Reports Third Quarter 2023 Results

Retrieved on: 
Friday, December 8, 2023

LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports unaudited, financial results for the quarter ended September 30, 2023.

Key Points: 
  • LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports unaudited, financial results for the quarter ended September 30, 2023.
  • Non-regulated revenues for the third quarter of 2023 increased 2.1% to $17.5 million from the prior year’s third quarter $17.2 million.
  • OTHER EXPENSES – Other expenses increased to $0.6 million in the third quarter of 2023, versus $0.3 million in the prior year’s third quarter, reflecting higher interest expense.
  • EARNINGS PER SHARE – Earnings per share prior to discontinued operations for the third quarter of 2023 were $195 per share.

Cool Company Ltd.: Granting Of Share Options And Restricted Stock Units To Primary Insiders and Mandatory Notification of Trades

Retrieved on: 
Friday, December 1, 2023

The Company anticipates that the shares underlying the vested RSUs will be issued to grantees on or after December 7, 2023.

Key Points: 
  • The Company anticipates that the shares underlying the vested RSUs will be issued to grantees on or after December 7, 2023.
  • Additionally, the Company’s board of directors (the “Board”) has resolved, in accordance with the LTIP, to authorize options (“Options”) and RSUs for 2023, as further detailed below.
  • Richard Tyrrell, CEO and Director of the Company, has on December 1, 2023 acquired 2,030 shares in the Company at a price of USD 12.49 per share.
  • The following Primary Insiders have been granted Options and RSUs, and purchased shares as per the below:
    Sami Iskander (Director) has been granted 37,123 Options.

Lemonade Announces Filing of Form S-3 Shelf Registration Statement

Retrieved on: 
Thursday, November 9, 2023

The Shelf Registration would also permit the Company to offer and sell its common stock, preferred stock, debt securities, warrants, purchase contracts and units, from time to time, subject to market conditions and the Company’s capital needs.

Key Points: 
  • The Shelf Registration would also permit the Company to offer and sell its common stock, preferred stock, debt securities, warrants, purchase contracts and units, from time to time, subject to market conditions and the Company’s capital needs.
  • The Company has no immediate plans to offer or sell any securities under this Shelf Registration to the public.
  • A Certified B-Corp, Lemonade gives unused premiums to nonprofits selected by its community, during its annual Giveback.
  • Lemonade is currently available in the United States, Germany, the Netherlands, France, and the UK, and continues to expand globally.

MOËT & CHANDON AND ROGER FEDERER ARE PROUD TO PRESENT A SHORT MOVIE IN WHICH ENERGY, ANTICIPATION, AND PLAY DEFINE A VERY SPECIAL DINNER CELEBRATION

Retrieved on: 
Wednesday, December 13, 2023

PARIS, Dec. 13, 2023 /PRNewswire/ -- Moët & Chandon proudly presents a short movie sparkling with festive ambiance and joie de vivre, starring the Maison's long-time brand ambassador Roger Federer. The video chronicles the adventures of the legendary athlete as he organizes an exquisite dinner à la Moët. Friends of the House are there to accompany him, each a personification of a field where Moët & Chandon has always played—and continues to play—a fundamental role: sports, fashion, cinema, gastronomy and oenology.

Key Points: 
  • PARIS, Dec. 13, 2023 /PRNewswire/ -- Moët & Chandon proudly presents a short movie sparkling with festive ambiance and joie de vivre, starring the Maison's long-time brand ambassador Roger Federer.
  • The video chronicles the adventures of the legendary athlete as he organizes an exquisite dinner à la Moët.
  • With its own rich heritage spanning two centuries, Château de Saran encapsulates the essence and legacy of Moët & Chandon.
  • The movie is featured on the official website and on the official Instagram , Facebook and YouTube accounts of Moët & Chandon.

MOËT & CHANDON AND ROGER FEDERER ARE PROUD TO PRESENT A SHORT MOVIE IN WHICH ENERGY, ANTICIPATION, AND PLAY DEFINE A VERY SPECIAL DINNER CELEBRATION

Retrieved on: 
Wednesday, December 13, 2023

PARIS, Dec. 13, 2023 /PRNewswire/ -- Moët & Chandon proudly presents a short movie sparkling with festive ambiance and joie de vivre, starring the Maison's long-time brand ambassador Roger Federer. The video chronicles the adventures of the legendary athlete as he organizes an exquisite dinner à la Moët. Friends of the House are there to accompany him, each a personification of a field where Moët & Chandon has always played—and continues to play—a fundamental role: sports, fashion, cinema, gastronomy and oenology.

Key Points: 
  • PARIS, Dec. 13, 2023 /PRNewswire/ -- Moët & Chandon proudly presents a short movie sparkling with festive ambiance and joie de vivre, starring the Maison's long-time brand ambassador Roger Federer.
  • The video chronicles the adventures of the legendary athlete as he organizes an exquisite dinner à la Moët.
  • With its own rich heritage spanning two centuries, Château de Saran encapsulates the essence and legacy of Moët & Chandon.
  • The movie is featured on the official website and on the official Instagram , Facebook and YouTube accounts of Moët & Chandon.

Relais & Châteaux chefs pledge to stop serving eel with immediate effect to prevent its extinction

Retrieved on: 
Tuesday, December 5, 2023

PARIS, Dec. 5, 2023 /PRNewswire/ -- The members of Relais & Châteaux's World Culinary Council has voted to immediately remove eel from their own menus and are sending a call to action to the rest of the group's 580 hotels and restaurants to do the same, after its NGO partner Ethic Ocean launched an alert that public authorities must urgently listen to scientists who recommend suspending European eel fishing.

Key Points: 
  • In this context, the 21 Relais & Châteaux chefs elected to the Association's World Culinary Council gathered in October and voted to approve an immediate ban of European eel from its menus.
  • As the world's largest network of chefs, Relais & Châteaux hopes to save this species."
  • Laurent Gardinier said: "We have an acute understanding that Relais & Châteaux, and our very art de vivre, is dependent on nature.
  • To learn more about sustainability at Relais & Châteaux, the Association's annual report with 15 objectives for 2025 and 2030 can be found here:

Relais & Châteaux chefs pledge to stop serving eel with immediate effect to prevent its extinction

Retrieved on: 
Tuesday, December 5, 2023

PARIS, Dec. 5, 2023 /PRNewswire/ -- The members of Relais & Châteaux's World Culinary Council has voted to immediately remove eel from their own menus and are sending a call to action to the rest of the group's 580 hotels and restaurants to do the same, after its NGO partner Ethic Ocean launched an alert that public authorities must urgently listen to scientists who recommend suspending European eel fishing.

Key Points: 
  • In this context, the 21 Relais & Châteaux chefs elected to the Association's World Culinary Council gathered in October and voted to approve an immediate ban of European eel from its menus.
  • As the world's largest network of chefs, Relais & Châteaux hopes to save this species."
  • Laurent Gardinier said: "We have an acute understanding that Relais & Châteaux, and our very art de vivre, is dependent on nature.
  • To learn more about sustainability at Relais & Châteaux, the Association's annual report with 15 objectives for 2025 and 2030 can be found here:

Ubie's AI Symptom Checker Used by 2 Million Americans in First Year, Fueling Pharma Partnerships

Retrieved on: 
Monday, December 4, 2023

NEW YORK, Dec. 4, 2023 /PRNewswire/ -- Ubie, a forerunner in the digital health arena, proudly announces a notable achievement that underscores its commitment to revolutionizing healthcare: Ubie's AI Symptom Checker has been used more than 2 million times in the U.S. since its introduction to the market just over a year ago. This milestone demonstrates the significant traction the tool has gained among individuals eager to better understand and manage their health.

Key Points: 
  • Ubie, a trailblazing AI-driven healthcare company, has achieved a new milestone with its AI Symptom Checker, surpassing 2 million uses in the U.S. in just over a year.
  • Leveraging this expanding user engagement, Ubie is advancing its partnerships with pharmaceutical companies to promote early disease detection and treatment.
  • This milestone demonstrates the significant traction the tool has gained among individuals eager to better understand and manage their health.
  • For more information about Ubie and its AI Symptom Checker, please visit Ubie AI Symptom Checker .

LUCARA ANNOUNCES OPERATING GUIDANCE FOR 2024 AND CFO APPOINTMENT

Retrieved on: 
Wednesday, November 29, 2023

The Company expects to monetize the +10.8 carat stones currently held in inventory in 2024.

Key Points: 
  • The Company expects to monetize the +10.8 carat stones currently held in inventory in 2024.
  • A portion of the  tonnes mined in 2024 will be stockpiled, prior to the end of open pit mining in mid-2025.
  • Lucara is pleased to announce that Glenn Kondo will be rejoining the Company as its Chief Financial Officer and Corporate Secretary effective January 1, 2024.
  • His previous experience at Lucara will be instrumental in delivering on the key financial fundamentals which drive shareholder returns."

The PolG Foundation awards over $3.5M in academic grants to pioneer POLG research

Retrieved on: 
Wednesday, November 15, 2023

Frederik de Nassau, a POLG warrior and son of founding parents, designs a MITO clothing line to raise awareness and funds for The PolG Foundation.

Key Points: 
  • Frederik de Nassau, a POLG warrior and son of founding parents, designs a MITO clothing line to raise awareness and funds for The PolG Foundation.
  • View Shop - https://shopmito.polgfoundation.org/
    A central pillar of the Foundation is to raise funding and provide grants to world-class investigators of basic science, clinical trial research and development of novel therapies for PolG mitochondrial disorders in both paediatric and adult PolG populations.
  • Today, The PolG Foundation is pleased to announce four awardees granted to our first Call for Research Initiatives proposals.
  • With your help and financial backing we can further our ambitious mission by discovering new therapies and a potential cure for PolG.